Related Experiment Video
Updated: Jun 24, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Michael Schotsaert1, Marina De Filette, Walter Fiers
1Department for Molecular Biomedical Research, Ghent University Technologpierpark 927, B-9052 Ghent, Belgium.
Expert Review of Vaccines
|April 8, 2009
Summary
Current influenza vaccines require annual updates. A novel vaccine targeting the conserved M2 ectodomain (M2e) of influenza A virus shows promise for broad protection against multiple strains and subtypes, including during pandemics.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Existing influenza vaccines are strain-specific, necessitating annual reformulation to match predicted epidemic strains.
- The unpredictability of influenza virus strain evolution, particularly for pandemic strains, limits the effectiveness of current vaccines.
- A universal influenza vaccine approach targeting conserved viral components is needed for broader and more durable protection.
Purpose of the Study:
- To review the development and clinical potential of a novel influenza vaccine strategy.
- To focus on vaccines based on the conserved ectodomain of the matrix protein 2 (M2e) of influenza A virus.
- To assess the feasibility of M2e-based vaccines for mitigating epidemic and pandemic influenza A infections.
Main Methods:
- Review of scientific literature and studies on M2e-based influenza vaccine candidates.
- Analysis of data from animal models demonstrating protection against influenza A virus challenge.
- Evaluation of clinical data from Phase I studies assessing safety and immunogenicity in humans.
Main Results:
- Numerous studies since 1999 have shown protection against influenza A virus in animal models using M2e fusion constructs.
- Recent Phase I clinical trials indicate that M2e vaccine candidates are safe and immunogenic in humans.
- The conserved nature of M2e offers a potential target for a universal influenza vaccine.
Conclusions:
- Vaccines based on the conserved M2 ectodomain (M2e) represent a promising alternative to current strain-specific influenza vaccines.
- Preclinical and early clinical data support the safety and immunogenicity of M2e-based vaccine candidates.
- Future human efficacy studies are crucial to validate the potential of M2e vaccines in preventing epidemic and pandemic influenza A.
Related Concept Videos
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...